Page last updated: 2024-11-06

lysergic acid diethylamide and Corneal Diseases

lysergic acid diethylamide has been researched along with Corneal Diseases in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Corneal Diseases: Diseases of the cornea.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lo, D1
Cobbs, L1
Chua, M1
Young, J1
Haberman, ID1
Modi, Y1

Other Studies

1 other study available for lysergic acid diethylamide and Corneal Diseases

ArticleYear
"Eye Dropping"-A Case Report of Transconjunctival Lysergic Acid Diethylamide Drug Abuse.
    Cornea, 2018, Volume: 37, Issue:10

    Topics: Adolescent; Conjunctival Diseases; Corneal Diseases; Eye Hemorrhage; Hallucinogens; Humans; Lysergic

2018